Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. - Wikidata - wikimedia - TriplyDB

Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution.

Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution.

http://www.wikidata.org/entity/Q34578979

about

Gemcitabine-based chemotherapy for advanced biliary tract carcinomas Diagnostic and therapeutic biomarkers in pancreaticobiliary malignancy Hepatobiliary Tumors: Update on Diagnosis and Management Limits of Surgical Resection for Bile Duct Cancer Liver transplantation for cholangiocarcinoma: Current status and new insights Current diagnostic and management options in perihilar cholangiocarcinoma Imaging and interventions in hilar cholangiocarcinoma: A review Resectable Cholangiocarcinoma: Reviewing the Role of Adjuvant Strategies Cancer review: Cholangiocarcinoma Cholangiocarcinoma The rise of the FGFR inhibitor in advanced biliary cancer: the next cover of time magazine?Cholangiocarcinoma: Current Knowledge and New Developments Yttrium-90 microspheres: a review of its emerging clinical indications DNA Methylation of PITX2 and PANCR Is Prognostic for Overall Survival in Patients with Resected Adenocarcinomas of the Biliary Tract Management of perihilar cholangiocarcinoma in the era of multimodal therapy Classification, diagnosis, and management of cholangiocarcinoma Epidemiology and risk factors: intrahepatic cholangiocarcinoma.Update on the Diagnosis and Treatment of Cholangiocarcinoma.The effect of preoperative chemotherapy treatment in surgically treated intrahepatic cholangiocarcinoma patients-A multi-institutional analysis.The Impact of Surgical Margin Status on Long-Term Outcome After Resection for Intrahepatic Cholangiocarcinoma.Identification of active chemotherapy regimens in advanced biliary tract carcinoma: a review of chemotherapy trials in the past two decades Role of endoscopic ultrasonography in the evaluation of extrahepatic cholangiocarcinoma Intrahepatic cholangiocarcinoma Liver transplantation for malignancy: current treatment strategies and future perspectives.Clinicopathological analysis and prognosis of extrahepatic bile duct cancer with a microscopic positive ductal margin Perihilar Cholangiocarcinoma: Number of Nodes Examined and Optimal Lymph Node Prognostic Scheme.Upregulated long noncoding RNA PANDAR predicts an unfavorable prognosis and promotes tumorigenesis in cholangiocarcinoma Update on Treatment Options for Advanced Bile Duct Tumours: Radioembolisation for Advanced Cholangiocarcinoma.Pancreaticoduodenectomy for secondary periampullary cancer following extrahepatic bile duct cancer resection.Selective internal radiotherapy (SIRT) versus transarterial chemoembolization (TACE) for the treatment of intrahepatic cholangiocellular carcinoma (CCC): study protocol for a randomized controlled trial.Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors Selective hypertrophy of the lobus caudatus as a novel approach enabling extended right hepatectomy in the presence of a non-perfused left lateral liver lobe Concurrent analysis of human equilibrative nucleoside transporter 1 and ribonucleotide reductase subunit 1 expression increases predictive value for prognosis in cholangiocarcinoma patients treated with adjuvant gemcitabine-based chemotherapy Prognostic significance of epithelial-mesenchymal transition-related markers in extrahepatic cholangiocarcinoma: comprehensive immunohistochemical study using a tissue microarray A phase II trial of the proteasome inhibitor bortezomib in patients with advanced biliary tract cancers.R0 but not R1/R2 resection is associated with better survival than palliative photodynamic therapy in biliary tract cancer.Genome-wide single nucleotide polymorphism array analysis reveals recurrent genomic alterations associated with histopathologic features in intrahepatic cholangiocarcinoma.Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma.Development of a questionnaire (EORTC module) to measure quality of life in patients with cholangiocarcinoma and gallbladder cancer, the EORTC QLQ-BIL21.Surgical strategy for bile duct cancer: Advances and current limitations.

P2860

Q24187573-A5914473-08FD-4363-BBDF-07170AF94C87 Q26767120-3FEF7631-F53B-4DDE-9C47-209E140FE509 Q26775654-DAA4F346-5000-4524-8369-81588B368427 Q26782869-77C6AA14-F056-4DDF-8CF2-65A6D5585A53 Q26783361-34B2C86C-097F-48EF-BC31-722DBE0C3C80 Q26822808-3ED92281-FBC0-4A3A-8435-994037B43BCC Q26823900-E49D35D6-0F33-47CE-AB09-C41E2055E7DE Q26849394-0B613346-977D-4BFD-9255-D1D561592F05 Q26865200-8D1AF089-D6EE-4434-BEC4-A6564B9406DD Q27001694-8256820B-B738-450E-BC1B-76C0E5B60109 Q28074145-750DB1AD-4BC5-4E40-8B70-74984F6A1A6E Q28076098-EFD7D46B-55A4-4059-BE2E-E564DE5F5254 Q28083856-9C46A60F-C5E2-4138-962B-E62228937DE0 Q28109676-8F57C580-5A65-4EA6-9D2D-E5309AF34B54 Q28273788-B941F760-4FCC-45D3-9AB1-73A78A18232F Q28275153-152DC43F-8BEB-4A15-90BB-E7076DBFD69F Q30234461-03A9679B-CCBD-49A0-B279-C613935E16C2 Q30238895-481D38C0-B27D-4A42-8C2D-6FD0E9743A40 Q30274956-279BE60B-EAA7-47A1-9F8A-3696C9E3370D Q30300388-1FA2C062-0B43-49A3-8428-13C56DF04B2B Q30300756-5AD7B1F6-3F23-43B1-BD77-16EF310E5E1A Q30436424-CCD02F92-741E-44B9-80C3-3BF96BE04728 Q33555135-3E5B20ED-C3FB-471B-8B37-EEF388D28533 Q33594868-B16938A7-5C5D-4E39-86E3-4E946679F99F Q33720952-C3E2F49D-CCEE-41C8-8D5C-CC2B7B2FD751 Q33742377-4D168800-7B48-4FAA-BD2E-8E6A225FDA1E Q33813109-876F803D-C549-4B98-8786-3D5D932DF774 Q33844564-239700E5-CE97-4134-9E08-9175B3E86FF0 Q34024501-234F51D1-A1B6-4735-ACEC-A25EAAB18748 Q34045215-BA2CB7C4-732F-4ADA-967F-D3D6C16DF0F2 Q34104493-2E6B3711-ECC9-48AC-9ADA-EC49B0CC8661 Q34252744-F9443C4B-B064-44DA-B755-9CEF19CA6CC8 Q34283650-177B59D2-6C85-4579-9C7F-56A872015AE0 Q34283703-1CCF9E20-7DDB-4679-A5ED-3DE3DFD0EE2B Q34307050-1A8A6E69-5475-445A-85F6-E97EE4C7AF73 Q34384390-D505D3C9-B948-4C1E-B4C3-1C7DD5EFCA5F Q34501733-8A10A270-7065-46F8-858A-ADAA154196E2 Q34614931-7C66698E-91DC-4DD3-8236-2ABC70630A0A Q34627921-05D09B8F-AEB3-4C1A-9A95-9493AF3B0D41 Q34629377-6B13954A-944A-4CFD-A3B8-94992E1320B4

P2860

Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution.

http://www.wikidata.org/entity/Q34578979

description

2007 nî lūn-bûn

@nan

2007 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution.

@ast

Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution.

@en

Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution.

@nl

type

label

Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution.

@ast

Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution.

@en

Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution.

@nl

prefLabel

Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution.

@ast

Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution.

@en

Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution.

@nl

P1433

Q34578979-B8DFD94C-9495-478B-8789-3AFF488DEEEC

P1476

Q34578979-62E33638-1EFF-42B2-A5B7-B1D1092F0F4F

P2093

Q34578979-1330CC59-89CA-4F15-A2D9-5506B4F43895

Q34578979-16C9E1C9-6508-4B72-B3C3-68080DBC5E9E

Q34578979-2975696C-44A5-48B6-B6BD-086EC79CA95A

Q34578979-2AF2F6F1-C54C-4C8C-BF79-1A478FA687C2

Q34578979-65265D72-E4E3-4CE8-B4E7-0C296162322C

Q34578979-8277A912-9C61-4C6B-83E3-FFB02049449F

Q34578979-8DB35297-DED8-439E-B485-2319F574CE32

Q34578979-C631803A-ADA5-4BF2-A5D7-ADF25BB2127C

Q34578979-EC91A5B0-BED9-4ACC-A7CB-4F039A59E99C

P2860

Q34578979-02CE668E-6856-4EB9-BCFF-3280A5D50DBA

Q34578979-1647D823-462F-4117-90F7-448D3354495D

Q34578979-2CE957D6-BFC1-4018-AA34-F71B7338F11A

Q34578979-4F412212-82C4-467F-896A-8A55D4B74A21

Q34578979-6599DBCB-E0CE-4F2E-BC02-F43887135CCD

Q34578979-78D64916-C434-4D27-BDDE-0F2BF3D69E0B

Q34578979-87E57692-3C23-41B2-8084-E2B0257921DC

Q34578979-8960DC09-3131-4B84-9AAB-2CDF01D7456E

Q34578979-8B7DA9B0-533C-4AE5-9647-30B0763DD1D6

Q34578979-A13CE3DC-B7E6-479B-B368-E6BBB7C30456

P304

Q34578979-55A90AB0-02A8-43B5-8F26-E6C6656D3E5A

P31

Q34578979-F167610E-D81E-423E-A34D-1581C3F3A181

P356

Q34578979-0348CC57-8C5D-4A6A-9107-6CD6C5B081E4

P407

Q34578979-6374E111-133C-4CF3-9037-2C59ACDF7993

P433

Q34578979-41DE7D79-2354-4900-81A6-8C952CE1EDF6

P478

Q34578979-0566E45F-A7D1-4539-B672-E1D4326B077A

P577

Q34578979-39CF6B62-F996-4C22-A5F7-FB942F70876F

P5875

Q34578979-857BD3D4-12B7-4A5F-936E-7D80F122C732

P698

Q34578979-8C80D65D-722D-49A8-8B3D-AE131A341C71

P921

Q34578979-57CA7CFF-9C82-4ED9-B977-9CF1BD7329F0

Q34578979-FAC4E656-731B-4F97-B1BF-5C12C43A8BDF

P932

Q34578979-2B7C358C-AE4B-4BEF-8F91-755FCF02E65E

P356

01.SLA.0000251366.62632.D3

P1433

Annals of Surgery

P1476

Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution.

@en

P2093

Charles J Yeo

http://www.w3.org/2001/XMLSchema#string

Farin Kamangar

http://www.w3.org/2001/XMLSchema#string

John L Cameron

http://www.w3.org/2001/XMLSchema#string

Jordan M Winter

http://www.w3.org/2001/XMLSchema#string

Keith D Lillemoe

http://www.w3.org/2001/XMLSchema#string

Michael A Choti

http://www.w3.org/2001/XMLSchema#string

Michelle L DeOliveira

http://www.w3.org/2001/XMLSchema#string

Richard D Schulick

http://www.w3.org/2001/XMLSchema#string

Steven C Cunningham

http://www.w3.org/2001/XMLSchema#string

P2860

Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma

Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors

Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection.

Resection of intrahepatic cholangiocarcinoma: a Western experience.

Adenocarcinoma of the distal bile duct. A clinicopathologic outcome analysis after curative resection.

Surgery for hilar cholangiocarcinoma: the Johns Hopkins approach.

Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes.

Hepatic resection and transplantation for peripheral cholangiocarcinoma.

Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients.

Recent advances in the management of cholangiocarcinomas.

P304

755-762

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/01.SLA.0000251366.62632.D3

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

245

http://www.w3.org/2001/XMLSchema#string

P577

2007-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6372383

http://www.w3.org/2001/XMLSchema#string

P698

17457168

http://www.w3.org/2001/XMLSchema#string

P921

cholangiocarcinoma

P932

1877058

http://www.w3.org/2001/XMLSchema#string